Literature DB >> 20727442

Vasopressin for refractory hypotension in extremely low birth weight infants.

Margarita Bidegain1, Rachel Greenberg, Catherine Simmons, Chi Dang, C Michael Cotten, P Brian Smith.   

Abstract

Intravenous vasopressin at 0.01 to 0.04 units/kg/h increased median mean blood pressure from 26 mm Hg (range 18-44) to 41 mm Hg (range 17-90) by 12 hours of infusion (P=.002) and allowed weaning of catecholamines in a group of extremely low birth weight infants with refractory hypotension. Copyright (c) 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20727442      PMCID： PMC3073313          DOI： 10.1016/j.jpeds.2010.04.038

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


  12 in total

Review 1.  The pathogenesis of vasodilatory shock.

Authors:  D W Landry; J A Oliver
Journal:  N Engl J Med       Date:  2001-08-23       Impact factor: 91.245

2.  Vasopressin and relativity: on the matter of deficiency and sensitivity.

Authors:  Donald W Landry; Juan A Oliver
Journal:  Crit Care Med       Date:  2006-04       Impact factor: 7.598

3.  Vasopressin deficiency contributes to the vasodilation of septic shock.

Authors:  D W Landry; H R Levin; E M Gallant; R C Ashton; S Seo; D D'Alessandro; M C Oz; J A Oliver
Journal:  Circulation       Date:  1997-03-04       Impact factor: 29.690

4.  Intravenous arginine-vasopressin in children with vasodilatory shock after cardiac surgery.

Authors:  E B Rosenzweig; T J Starc; J M Chen; S Cullinane; D M Timchak; W M Gersony; D W Landry; M E Galantowicz
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

5.  The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series.

Authors:  C L Holmes; K R Walley; D R Chittock; T Lehman; J A Russell
Journal:  Intensive Care Med       Date:  2001-08       Impact factor: 17.440

6.  Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study.

Authors:  Martin W Dünser; Andreas J Mayr; Hanno Ulmer; Hans Knotzer; Günther Sumann; Werner Pajk; Barbara Friesenecker; Walter R Hasibeder
Journal:  Circulation       Date:  2003-05-05       Impact factor: 29.690

7.  Levels of catecholamines, arginine vasopressin and atrial natriuretic peptide in hypotensive extremely low birth weight infants in the first 24 hours after birth.

Authors:  Shoichi Ezaki; Keiji Suzuki; Clara Kurishima; Masumi Miura; Koichi Moriwaki; Hiroshi Arakawa; Tetsuya Kunikata; Hisanori Sobajima; Masanori Tamura
Journal:  Neonatology       Date:  2008-11-04       Impact factor: 4.035

8.  Vasopressin versus norepinephrine infusion in patients with septic shock.

Authors:  James A Russell; Keith R Walley; Joel Singer; Anthony C Gordon; Paul C Hébert; D James Cooper; Cheryl L Holmes; Sangeeta Mehta; John T Granton; Michelle M Storms; Deborah J Cook; Jeffrey J Presneill; Dieter Ayers
Journal:  N Engl J Med       Date:  2008-02-28       Impact factor: 91.245

Review 9.  Vasopressin in catecholamine-refractory shock in children.

Authors:  S Meyer; L Gortner; W McGuire; A Baghai; S Gottschling
Journal:  Anaesthesia       Date:  2007-12-13       Impact factor: 6.955

Review 10.  Necrotizing enterocolitis: treatment based on staging criteria.

Authors:  M C Walsh; R M Kliegman
Journal:  Pediatr Clin North Am       Date:  1986-02       Impact factor: 3.278
View more
  13 in total

Review 1.  Vein of Galen aneurysmal malformation: rationalizing medical management of neonatal heart failure.

Authors:  Melinda J Cory; Dimitrios Angelis; Phillippe Durand; Rafael Sillero; Luc Morin; Rashmin Savani; Lina Chalak
Journal:  Pediatr Res       Date:  2022-04-14       Impact factor: 3.756

Review 2.  Vital signs as physiomarkers of neonatal sepsis.

Authors:  Brynne A Sullivan; Karen D Fairchild
Journal:  Pediatr Res       Date:  2021-09-07       Impact factor: 3.756

3.  Low vasopressin and progression of neonatal sepsis to septic shock: a prospective cohort study.

Authors:  Abhishek S Aradhya; Venkataseshan Sundaram; Naresh Sachdeva; Sourabh Dutta; Shiv S Saini; Praveen Kumar
Journal:  Eur J Pediatr       Date:  2020-02-15       Impact factor: 3.183

4.  Use of vasopressin in neonatal hypertrophic obstructive cardiomyopathy: case series.

Authors:  Stephanie M Boyd; Kristin L Riley; Regan E Giesinger; Patrick J McNamara
Journal:  J Perinatol       Date:  2020-09-19       Impact factor: 2.521

5.  Vasopressin versus dopamine for treatment of hypotension in extremely low birth weight infants: a randomized, blinded pilot study.

Authors:  Danielle R Rios; Jeffrey R Kaiser
Journal:  J Pediatr       Date:  2015-01-29       Impact factor: 4.406

6.  Copeptin concentration in cord blood in infants with early-onset sepsis, chorioamnionitis and perinatal asphyxia.

Authors:  Luregn J Schlapbach; Stefanie Frey; Susanna Bigler; Chiem Manh-Nhi; Christoph Aebi; Mathias Nelle; Jean-Marc Nuoffer
Journal:  BMC Pediatr       Date:  2011-05-19       Impact factor: 2.125

Review 7.  Arginine Vasopressin and Copeptin in Perinatology.

Authors:  Katrina Suzanne Evers; Sven Wellmann
Journal:  Front Pediatr       Date:  2016-08-02       Impact factor: 3.418

Review 8.  Advances in Diagnosis and Management of Hemodynamic Instability in Neonatal Shock.

Authors:  Yogen Singh; Anup C Katheria; Farha Vora
Journal:  Front Pediatr       Date:  2018-01-19       Impact factor: 3.418

Review 9.  Role of vasopressin and terlipressin in refractory shock compared to conventional therapy in the neonatal and pediatric population: a systematic review, meta-analysis, and trial sequential analysis.

Authors:  Reem Masarwa; Gideon Paret; Amichai Perlman; Shimon Reif; Bruria Hirsh Raccah; Ilan Matok
Journal:  Crit Care       Date:  2017-01-05       Impact factor: 9.097

10.  Efficacy and safety of vasopressin and terlipressin in preterm neonates: a protocol for a systematic review.

Authors:  Abdulrahman Salim Alsaadi; Katelyn Sushko; Vivian Bui; John Van Den Anker; Abdul Razak; Samira Samiee-Zafarghandy
Journal:  BMJ Paediatr Open       Date:  2021-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.